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ertebrate-striated muscle is assumed to owe its re-
markable order to the molecular ruler functions of
the giant modular signaling proteins, titin and nebu-
lin. It was believed that these two proteins represented
unique results of protein evolution in vertebrate muscle. In
this paper we report the identiﬁcation of a third giant protein
from vertebrate muscle, obscurin, encoded on chromosome
 
1q42. Obscurin is 
 
 
 
800 kD and is expressed speciﬁcally in
skeletal and cardiac muscle. The complete cDNA sequence
of obscurin reveals a modular architecture, consisting of
 
 
 
67 intracellular immunoglobulin (Ig)- or ﬁbronectin-3–like
domains with multiple splice variants. A large region of ob-
V
 
scurin shows a modular architecture of tandem Ig domains
reminiscent of the elastic region of titin. The COOH-terminal
region of obscurin interacts via two speciﬁc Ig-like domains
 
with the NH
 
2
 
-terminal Z-disk region of titin. Both proteins
coassemble during myoﬁbrillogenesis. During the progres-
sion of myoﬁbrillogenesis, all obscurin epitopes become de-
tectable at the M band. The presence of a calmodulin-binding
IQ motif, and a Rho guanine nucleotide exchange factor do-
main in the COOH-terminal region suggest that obscurin is
 
involved in Ca
 
2
 
 
 
/calmodulin, as well as G protein–coupled
signal transduction in the sarcomere.
 
Introduction
 
Sarcomeres, the smallest contractile units of striated muscles,
are assembled from thousands of protein subunits into the
largest and most regular macromolecular complex known.
Sarcomeres are assembled during the embryonic differentia-
tion of heart and skeletal muscle, but also on a continuous
basis during the physiological turnover of muscle. New sar-
comeres are also formed at a high rate in hypertrophying
muscle: either as a result of exercise, increased pressure and
volume load of the heart, or pathological or hormonal stim-
ulation. The mechanisms which cooperate to regulate mus-
cle-specific gene transcription are only beginning to emerge
(Chien, 2000). It remains largely unclear how signaling at
the molecular level within the sarcomere and the control of
assembly are coordinated. Therefore, identifying and charac-
terizing key elements of sarcomeric signal transduction and
their roles in the control of myofibrillogenesis are essential to
elucidate basic mechanisms of the cell biology of muscle,
leading to a molecular understanding of associated diseases.
The process of myofibril assembly requires both spatial
and temporal coordination of protein interactions with high
precision (Gautel et al., 1999). To achieve this long-range
coordination, two giant modular proteins, acting as molec-
ular scaffolds or blueprints, are found in vertebrate mus-
cle. Titin (Wang et al., 1979), also known as connectin,
(Maruyama, 1976) and nebulin provide specific attachment
sites for other proteins and thus specify their sarcomeric po-
sitions (Trinick, 1996; Trinick and Tskhovrebova, 1999).
Recently, it was shown that the deletion of titin leads to a to-
tal loss of myofibril assembly despite the persisting ex-
pression of other sarcomeric proteins (Van der Ven et al.,
2000). Apart from binding sites for other sarcomeric pro-
teins, these giant proteins contain potential signaling domains:
a COOH-terminal Src homology 3 (SH3)* domain in neb-
ulin (Labeit and Kolmerer, 1995a), and multiple phosphor-
ylation sites and a COOH-terminal catalytic protein kinase
domain in titin implicated in myofibril assembly (Mayans et
al., 1998). These domains suggest that the molecular scaf-
fold proteins of the myofibril receive and propagate signals
from various pathways.
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Nematodes contain two large muscle proteins, encoded
by the unc-22 and unc-89 genes in 
 
Caenorhabditis elegans
 
.
The unc-22 product is twitchin, which is localized along
the myosin filament and shows homology to titin (Benian
et al., 1989). Unc-89 has been implicated in the assembly
of the sarcomeric M band (Benian et al., 1996); a mamma-
lian homologue of unc-89 has not been identified to date.
Titin, twitchin, and unc-89 are all at least partly associated
with the myosin filament. These proteins share a similar
molecular architecture, being largely composed of 100-resi-
due domains of the intracellular Ig superfamily, and also
contain domains involved in signal transduction (Benian et
al., 1989, 1996; Labeit et al., 1992; Heierhorst et al.,
1994). Titin and twitchin contain a myosin light chain ki-
nase–like protein kinase domain which has been implicated
in the control of myofibril formation in titin (Mayans et al.,
1998), whereas unc-89 contains a G protein–activating
GDP/GTP exchange factor domain (GEF domain; Benian
et al., 1996).
Among the giant proteins, the complex modular architecture
of titin is probably the one best understood at the functional
level, and may therefore serve as a paradigm for the analysis of
other large modular proteins. Apart from Ig-like domains, titin
contains unique sequences which are involved in signal trans-
duction or interactions with other sarcomeric proteins (Gautel
et al., 1999). Specific titin domains interact with myomesin,
myosin, myosin-binding protein C, 
 
 
 
-actinin, and telethonin
along the distance from M-line to Z-disk (Gautel et al., 1999;
Gregorio et al., 1999; Trinick and Tskhovrebova, 1999; Sanger
et al., 2000). These interactions specify the sarcomeric localiza-
tion of these other protein components and define the length
of myosin filaments or the thickness of the Z-disk (Gautel et
al., 1999). In the I-band, titin is composed of Ig domains ar-
ranged in tandem and a unique sequence, the so-called PEVK
region (Labeit and Kolmerer, 1995b). These two secondary
structure elements act as serial springs and are responsible for
the passive elasticity of muscle (Gautel and Goulding, 1996;
Linke et al., 1996), with the tandem Ig stretch being largely re-
sponsible for extension at low forces and resisting stretch at
higher forces (Trinick, 1996).
Several pleiotropic signaling pathways control the forma-
tion of new sarcomeres in differentiating or hypertrophying
muscle, including the Src and p38–mitogen-activated ki-
nases, the phosphatidyl inositol 3 (PI3)-kinase pathways,
and the Rho-family of small G-proteins (Thorburn et al.,
1997; Wang et al., 1998; Cuenda and Cohen, 1999; Zetser
et al., 1999; Puri et al., 2000; Wu et al., 2000). Surprisingly,
it is as yet unclear whether these pathways directly link ex-
tracellular signals with the transcriptional machinery, or
whether they may actually communicate with, and be regu-
lated by, components of the sarcomere.
We report here the identification and initial characteriza-
tion of a novel giant protein which we term obscurin. Ob-
scurin is a modular protein of 
 
 
 
800 kD which contains a
GTPase nucleotide exchange factor (GEF) domain, is local-
ized in the myofibril, and therefore joins the family of giant
sarcomeric signaling proteins. Thus, obscurin provides a
possible direct link between the sarcomere and the G-pro-
tein regulated pathways which control the formation of new
myofibrils.
 
Results
 
An obscurin cDNA sequence contains an 
 
 
 
20-kb ORF
 
We have identified obscurin as a novel titin interacting pro-
tein in a yeast two hybrid screen (see below). Searches of the
EMBL and GenBank databases with this sequence retrieved
no identical cDNA sequence, suggesting the identification
of a novel protein. We have named this protein obscurin, af-
ter the adjective obscure, defined in the New Oxford Dictio-
nary as meaning: (a) difficult to see or make out, (b) not well
known, or (c) not easily understood. All three meanings are
appropriate to obscurin, which has not been identified pre-
viously and has proven difficult to characterize because of its
complexity, large size, and relatively low abundance.
Starting with the 750 bp of obscurin cDNA sequence from
positive yeast two hybrid clones, a lambda phage cardiac
cDNA library was screened in order to extend this sequence
in both directions. Multiple rounds of screening yielded a
panel of 18 cDNA clones which can be assembled into a 20.4
kb contig (Fig. 1 A). This cDNA encodes an ORF of 19,860
bp. The ORF is preceded by an in-frame stop codon 27-bp
upstream of a putative start methionine. The sequence pre-
ceding this methionine codon fits to the Kozak sequence
found around the start methionine of eukaryotic genes
(Kozak, 1989). The first domain starts nine amino acids after
the putative start methionine. At the 3
 
 
 
 end of the ORF there
is an in-frame stop codon followed by 500 bp of predicted 3
 
 
 
untranslated sequence which contains stop codons in all
reading frames. No consensus polyadenylation signal was
identified, although the 3
 
 
 
 untranslated region shows perfect
homology to several entries from the EST database which
were cloned using oligo dT primers. The ORF is predicted to
encode a 720-kD protein of 6,620 amino acids. One shorter
splice variant was sequenced (termed obscurin-a1). Attempts
to further characterize alternative splice variants by reverse
transcriptase PCR failed because of the low abundance of the
obscurin message and the extreme homology over most of
the tandem Ig-regions (see below).
 
Obscurin is a modular protein built from adhesion 
modules and signaling domains
 
The deduced amino acid sequence from the cDNA reveals a
highly modular architecture (Fig. 1 B). The NH
 
2
 
-terminal
region consists of 49 Ig and 2 fibronectin (Fn)3 domains, ar-
ranged mostly in tandem. This repetitive region is followed
by a complex region, consisting of four further Ig domains
separated by nonmodular sequences. Just NH
 
2
 
-terminal to
the first of these Ig domains is an IQ motif. After this region
there is an SH3 domain next to tandem dbl homology (DH)
and pleckstrin homology (PH) domains. The COOH-ter-
minal end of the protein consists of two tandem Ig domains
followed by a nonmodular region of 417 amino acids con-
taining several copies of a consensus phosphorylation motif
(SPXR) for ERK kinases similar to that found in the NH
 
2
 
-
terminal region of titin (Gautel et al., 1996a). Data base
searches with the nonmodular interdomain sequences show
no clear homology to known protein domains apart from
those described. In our domain nomenclature we label both
Ig and Fn3 domains in the longest cardiac isoform consecu-
tively from NH
 
2
 
 to COOH terminus with the prefix Ob 
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(i.e., Ob1, Ob2…Ob57). This 57-domain splice form is
called obscurin. Further splice variants are called obscurin-
a1 and so forth, and their additional domains, Oba1, etc.
 
The obscurin gene structure
 
Using our cDNA sequences as a guide, we analyzed the draft
human genomic sequence (Lander et al., 2001) and identified
10 contiguous sequences from chromosome 1q42 which cover
most of the obscurin gene, designated OBSCN. After correct
orientation and ordering of these contigs, the assembled se-
quence reveals the genomic organization of the obscurin gene
with nine gaps of undefined length (Fig. 1 C). This partial se-
quence contains exons corresponding to all of our cDNA se-
quence with the exception of three regions corresponding to
the obscurin domains Ob3–Ob4, Ob11, and Ob18. For the
most part the tandem Ig and Fn3 domains are encoded one
domain per exon, similarly to the titin gene (Kolmerer et al.,
1996). The signaling domains, nonmodular sequences, and Ig
domains at the COOH terminus, however, do no follow this
pattern. Putative exons encoding ten additional Ig domains
not represented in our cDNA sequence were identified within
the tandem Ig region of the molecule. This provides evidence
for further splicing in this region, which is supported by addi-
tional partly sequenced cDNA clones from this region (not
shown). The incomplete obscurin gene available to date con-
tains at least 68 Ig/Fn3 domains (precluding a final domain
nomenclature for the moment), which are likely to be ex-
pressed as numerous splice variants.
 
Ig domains
 
A multiple sequence alignment and phylogenic tree of the Ig
domains (Fig. 2, A and B) reveals no obvious repeat or su-
per-repeat pattern, which is in contrast to the arrangement
of Ig domains in titin (Labeit et al., 1992; Gautel, 1996) or
the helical repeats in nebulin (Labeit and Kolmerer, 1995a;
Wang et al., 1996; Fig. 2, A and B). The Ig domains be-
tween the two Fn3 domains are all 88–92 amino acids in
length and arranged with no linker sequence between them
(except for short linkers between Ob2 and Ob3, and be-
tween Ob24 and Ob25). In this region two clusters of ex-
tremely homologous domains can be identified (Fig. 2 B).
The domains in these two clusters (Ob36–42 and Ob9–18;
purple and green in Fig. 2 B) are between 72 and 90% iden-
tical to each other at the protein level. At the DNA level
there are as few as 20 bases which differ between DNA se-
quences encoding adjacent domains. Titin I–band domains
show a compact 
 
 
 
-barrel domain (Improta et al., 1996),
partly due to the short length of the loops linking adjacent
 
 
 
-strands F and G. In the central obscurin domains, the
length of this loop is equally short. The Ig domains at the
NH
 
2
 
 and COOH terminus of the molecule (1–3 and 53–
57) cluster together in the phylogenetic tree (Fig. 2 B), but
are less homologous to each other than the tandem Ig do-
mains in the center of the molecule. They are more similar
to the terminal domains of titin, e.g., M5 (Pfuhl and Pas-
tore, 1995), and vary more in size, (e.g., Ig 55 contains 100
amino acids). It is likely that they formed part of a smaller
ancestral molecule which grew much larger by rapid duplica-
tion of the central tandem domains. One splice variant, ob-
scurin-a1, was sequenced in which an additional Ig domain
(Oba1) replaces Ob10–16 (Fig. 1 B).
 
Signaling domains
 
The nonmodular insertion NH
 
2
 
-terminal to Ig52 contains
an IQ motif, so called for the conserved sequence Ile-Gln
found in these 
 
 
 
-helical peptides. This motif is a recognized
binding motif for calmodulin or calmodulin-like proteins,
such as myosin light chains (Rhoads and Friedberg, 1997).
Figure 1. The cDNA and genomic se-
quence of obscurin. (A) Positions of iso-
lated obscurin cDNAs. A total of 20,435 
bp of continuous cDNA sequence can be 
assembled from the depicted overlapping 
cDNAs. This cDNA sequence contains 
an ORF encoding 6,620 amino acids. (B) 
Domain pattern of obscurin. The de-
duced amino acid sequence predicts a 
protein of 721,685 kD. Within this se-
quence, known protein domains were 
identified by database searches and vi-
sual inspection. Obscurin is a polar mol-
ecule with signal transduction domains 
in the COOH-terminal region and repet-
itive tandem Ig domains NH2-terminal to 
the signaling region. The Ig and Fn3 
modules are numbered consecutively 
from the NH2 terminus. Ig, immunoglob-
ulin-like; IQ, IQ calmodulin binding 
motif. One shorter alternatively spliced 
variant was sequenced and the extra Ig 
domain from this splice variant is de-
noted a1. The positions of the epitopes 
for antibodies used in this study are indicated above the domain structure. (C) Partial structure of the obscurin gene. A  150-kb obscurin ge-
nomic sequence was compiled by analyzing the draft human genome sequence. Exons are indicated as vertical black lines with the position 
of the exons encoding selected domains indicated above. Putative exons encoding 10 Ig domains which are not present in the cDNA se-
quence are marked by an asterisk. Long vertical grey lines indicate gaps of undefined length in the sequence. 
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Figure 2. Comparison of obscurin Ig domains. (A) Multiple sequence alignment of all obscurin Ig domains using ClustalW (Higgins et al., 
1996). Note the extremely high homology of some groups of adjacent domains. Also included are titin M5 and I27 domains whose structures 
have been solved. The seven  -strands of M5 (top) and I27 (bottom) are indicated as bars under the alignment (Pfuhl and Pastore, 1995; Im-
prota et al., 1996). This alignment was used to generate the phylogenetic tree in B. Residue coloring: all prolines, yellow; all glycines, brown; 
conserved basic residues, pink; conserved acidic residues, purple; conserved hydrophobic residues, blue. (B) A phylogenetic tree of the ob-
scurin Ig domains does not reveal any patterns of super repeats as seen in titin. In some regions, consecutive domains cluster together and are 
highly homologous, for example domains Ob9–15 and Ob36–42 (green and purple, respectively). This suggests a rapid expansion of the do-
main pattern during the evolution of the protein. The three NH2-terminal domains (blue) cluster together with the five most COOH-terminal 
ones (red). The titin binding domains Ob48 and Ob49 are colored yellow. 
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The IQ motif in obscurin shows highest homology to simi-
lar motifs in the neuronal proteins neuromodulin and neu-
rogranin (Slemmon et al., 1996).
Further signaling domains follow from amino acid 5,601
onwards. This region contains an SH3 domain which is
43% identical to the SH3 domain of the 
 
C. elegans
 
 protein
UNC-89. However, it is not very similar to other SH3 do-
mains, including those of the muscle Z-disk proteins nebu-
lin or ArgBP2 (Wang et al., 1997). Adjacent to the SH3 do-
main is a DH domain, also known as a RhoGEF domain. As
in all DH domain–containing proteins, a PH domain fol-
lows immediately thereafter. The obscurin DH and PH do-
mains are most homologous (
 
 
 
25% identity) to the simi-
larly arranged domains in dbl, Vav, trio, kalirin and unc-89.
The obscurin DH domain contains a proline rich sequence
not found in other DH domains.
 
Obscurin is a giant protein expressed 
in cardiac and skeletal muscle
 
To monitor the expression of obscurin protein and gain esti-
mates of the size distributions of the polypeptide, the rab-
bit polyclonal antisera 
 
 
 
-Ob19–20, 
 
 
 
-Ob48–49, 
 
 
 
-Ob-
DH and 
 
 
 
-Ob51–52 were raised (Fig. 1). 
 
 
 
-Ob48–49,
 
 
 
-Ob51–52 and 
 
 
 
-Ob-DH were affinity purified and used
to detect obscurin on Western blots from low porosity SDS
polyacrylamide gels. Using 
 
 
 
-Ob48–49 and 
 
 
 
-Ob-DH to
probe blots of human 
 
Vastus lateralis 
 
muscle, a very high
molecular weight protein was detected (Fig. 3). This protein
was seen to migrate slightly slower than the visible nebulin
band. A band of similar molecular weight was detected on
blots of cardiac tissue (Fig. 3). The blots were also probed
with anti-titin antibodies. Although titin can be detected,
the obscurin band does not react with several anti-titin anti-
bodies (S54-4 and CH11, Whiting et al., 1989; Gautel et
al., 1996b). 
 
 
 
-Ob48–49 and 
 
 
 
-Ob-DH react with neither
nebulin nor titin. Nebulin has a molecular weight of 
 
 
 
700–
900 kD (Labeit and Kolmerer, 1995a; Wang et al., 1996)
and thus obscurin is expected to be of a similar or slightly
larger size. This is in agreement with the molecular weight of
at least 720 kD predicted for obscurin from the cDNA se-
quence. A band of similar size is also detected using the
 
 
 
-Ob-DH antibody (Fig. 3). On Coomassie-stained low
porosity gels with normal loading (20–40 
 
 
 
g total protein)
of adult muscle, there is no appreciable protein in the region
between nebulin and titin (Fig. 3), suggesting that obscurin
is expressed at much lower levels than either of these pro-
teins. Estimations by densitometric analysis of double-
probed Western blots of adult skeletal muscle suggest that
the ratio of nebulin to obscurin is at least 10:1.
All our obscurin cDNAs were obtained either from a hu-
man skeletal muscle cDNA library or from a human cardiac
lambda phage library. On multiple tissue Northern blots,
the obscurin message was barely detectable, probably due to
low abundance and difficulties in blotting such a large
mRNA. Using dot blots of total RNA, an obscurin probe
hybridized specifically to RNA from cardiac and skeletal
muscle (not shown). The EST databases contain entries cor-
responding to COOH-terminal regions of obscurin. Most of
these entries are derived from cardiac or skeletal muscle
mRNA. Together these data suggest that obscurin is an
 
 
 
700–800 kD protein expressed in striated muscle.
 
Z-disk titin interacts with obscurin by homotypic 
binding to two specific obscurin Ig domains
 
Obscurin was identified in a systematic search for proteins
interacting with the peripheral Z-disk region of titin, using
the bait Z7-Z10 to screen a skeletal muscle cDNA library in
the two-hybrid system. The bait is ultrastructurally located
at the comb-like transition region of the peripheral Z-disk
(Gautel et al., 1996a; Yajima et al., 1996). The yeast two-
hybrid screen yielded over 200 HIS3 and 
 
 
 
-galactosidase
positive clones from several complexities of the library. Nine
of these were sequenced and all were found to encode Ig do-
mains 48 and 49 of obscurin followed by either a truncated
(e.g., clone no. 27) or complete (e.g., clone no. 25) Fn3 do-
main (Ob50; Fig. 4 A).
The obscurin binding site was mapped on titin by testing
for interaction with titin Z7-Z8 and Z9-Z10. The interac-
tion with obscurin was mapped to Z9-Z10 (Fig. 4 A). The
individual titin Ig domains Z9 or Z10 show only a very
Figure 3. Detection of obscurin by Western blotting. (A) The poly-
clonal antibody  -Ob48–49 against obscurin detects a large protein 
of approximately the same size as nebulin in striated muscle. Lanes 
1, 2, and 3: human Vastus lateralis muscle sample run on 3% poly-
acrylamide gel. Lane 1, Coomassie stain of a lane from the gel; lane 
2, titin detected with S53 monoclonal antibody on a Western blot of 
one lane from the same gel; lane 3, obscurin detected with  -Ob48–
49 polyclonal antibody on a Western blot of an adjacent lane. Note, 
titin and nebulin were well blotted and their positions are marked 
on the blot. Titin is resolved as a single band. Obscurin is detected 
slightly above the position of nebulin as marked on the blot. Lanes 
4–7, human Vastus lateralis muscle sample run on 4% polyacryl-
amide gel. Lane 4, Coomassie stain of a lane from the gel; lane 5; 
obscurin detected with  -Ob48–49 on a lane cut from of a Western 
blot of the same gel; lane 6, the same blot as lane 5 stripped and 
reprobed with antinebulin NSH3-ra. Note, blots have been accu-
rately aligned and obscurin can be distinguished from nebulin. The 
 -Ob48–49 antibody has not been completely stripped from the 
blot, so, in lane 6 there is some carry over of the obscurin signal ap-
pearing just above the darker nebulin band. Lane 7, obscurin de-
tected with  -ObDH; lane 8, human cardiac muscle sample run on 
a 4% polyacrylamide gel. Obscurin detected with  -Ob48–49 on a 
Western blot. Note, a protein of a similar size is detected in cardiac 
and skeletal muscle. M, myosin; T, titin; N, nebulin; O, obscurin. 
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weak interaction with the same obscurin clone, whereas the
individual obscurin Ig domains Ob48 and Ob49 do not in-
teract with titin Z9-Z10 (not shown). The two-hybrid inter-
actions were confirmed in an in vitro assay using the recom-
binant fragments titin Z9-Z10 and obscurin Ob48–49.
Titin Z9-Z10 fragment was bound via a 6xHistidine tag to a
Ni–NTA matrix. The untagged obscurin fragment is specifi-
cally retained on the column only when mixed with Z9-Z10
(Fig. 4 B), confirming the interaction of both proteins. Iso-
thermal titration calorimetry indicated reproducible Kd val-
ues of 100–200 nM (not shown).
When an obscurin construct encompassing Ob48–51 was
transfected into neonatal rat cardiomyocytes, the transfected
protein was found to colocalize at the Z-disk with the titin
Z-disk epitope T12 (Fig. 4 C). This supports the notion that
the obscurin Ig domains Ob48–49, via their interaction
with titin Z9-Z10, constitute a functional Z-disk targeting
signal in obscurin.
 
Calcium-insensitive binding of calmodulin to the IQ motif
 
Ligands for the obscurin IQ domain were identified by a
yeast two hybrid screen using domains 51–52 as bait. The
IQ domain is immediately NH
 
2
 
-terminal to Ob52 and is
preceded by 
 
 
 
160 amino acids of nonmodular sequence.
Six of seven clones from this screen were found to encode
full-length calmodulin. To verify this interaction and to test
for Ca
 
2
 
 
 
 sensitivity of the interaction, binding of recombi-
nant Ob51–52 was assayed on calmodulin-Sepharose beads
in the presence and absence of Ca
 
2
 
 
 
. The Ob51–52 frag-
ment was found to bind to calmodulin-beads in a Ca
 
2
 
 
 
-
 
independent way (Fig. 5). Control obscurin fragments show
no calmodulin binding (not shown).
 
Assembly of obscurin into nascent sarcomeres
 
The in vitro interaction of obscurin and titin near the Z-disk
raises the question of the relative order of their incorpora-
tion, and the final localization of both proteins in the myo-
fibril. We therefore investigated their appearance in cultured
cardiomyocytes and in developing hearts, using a panel of
four anti-obscurin antibodies against different epitopes
along the molecule (Fig. 1, Table I).
In neonatal rat cardiomyocytes, endogenous obscurin was
found to localize at the M-band as detected by all four anti-
bodies. Occasional weak Z-disk staining was observed only
with 
 
 
 
-Ob48–49, which binds to the titin binding site (Fig.
6). Since myofibrillogenesis in vivo is not always faithfully
reflected in detail in cultured cardiac myocytes (Ehler et al.,
1999), we used the same antibodies on whole-mount prepa-
rations of embryonic chicken, mouse and rat hearts span-
ning early to late stages of heart development.
The earliest epitope to show sarcomeric localization is that
of the titin binding domains, Ob48–49. In agreement with
the transfection data and in vitro binding results, 
 
 
 
-Ob48–49
stains Z-disks in early chicken embryos up to about the 10-
somite stage (Fig. 7). At these early stages, epitopes close to
Ob48–49 in the obscurin cDNA (Fig. 1 B), 
 
 
 
-Ob-DH and
 
 
 
-Ob51–52 are not detectable, or later on weakly expressed
and diffusely localized. At about S10, noticeable staining of
the M-band is observed with 
 
 
 
-Ob48–49, which increases
further with development and which is concomitant with a
Figure 4. Binding of titin and obscurin in yeast two-hybrid system and in vitro. (A) Yeast two-
hybrid analysis of the interaction between obscurin and titin. Titin domains Z7–Z10 (depicted 
as ovals) which were used as the primary two-hybrid bait is shown. One of the interacting 
clones obtained (clone no. 27) was used to further map the binding site on titin. The region Z9–
Z10 interacted as strongly as the original bait whereas Z7–Z8 did not interact in this assay. In-
teractions were assayed by cotransformation of bait and prey plasmids into L40 yeast cells and 
monitoring reporter gene activation. His3 gene activation is marked as  /  and  -galactosi-
dase activity is given as arbitrary units from liquid assays. Further separation of either titin Ig do-
mains Z9 and Z10 or obscurin Ig 48 and 49 abolishes the interaction, demonstrating that the 
tandem domains of both proteins are required to form a functional binding site. (B) In vitro 
binding of titin to obscurin. The histidine-tagged titin fragment Z9–Z10 was assayed for binding 
to an untagged obscurin fragment Ig48–49 on mini Ni-NTA agarose columns. Lane 1 shows a 
mixture of both proteins as used in the assay. Either such a mixture of both proteins (lanes 5–7), 
or the obscurin fragment alone (lanes 2–4), were loaded on the column. The obscurin fragment 
is retained on the column when mixed with the titin Z9–Z10 (lane 7, asterisk), whereas there is no unspecific binding (lane 4). Lanes 2 and 5, 
flow through fractions; lanes 3 and 6, wash fraction; lanes 4 and 7, eluate fraction; M, marker lane (sizes given in kD). (C) Ob48–51 is tar-
geted to the Z-disk in neonatal rat cardiomyocytes. The T7-tagged fragment was transfected into neonatal rat cardiomyocytes and detected by 
a tag-specific monoclonal antibody at the sarcomeric Z-disk (green), as demonstrated by the counterstain with myomesin at the M-band (red) 
in the overlay. Occasional weak M-band localization can also be observed (arrowhead). Overexpressed protein is also accumulating in the 
nuclei. Note that expression of Ob48–51 does not disrupt myofibrils. Bar, 8  m. 
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loss of Z-disk staining. In parallel with this shift in epitope
localization, the epitopes COOH- and NH
 
2
 
-terminal to
Ob48–49 become localized to the sarcomere and are detected
at the M-band. Similar observations were made in the myo-
fibrils of rodent hearts, since 
 
 
 
-Ob48–49 shows both weak
Z-disk as well as strong M-band staining (Fig. 7 D) in E9.5
mouse hearts, which is shortly after the onset of beating. In
the fully matured myofibrils of E14.5 rat hearts, adult rat and
mouse hearts, or neonatal rat cardiomyocytes, all obscurin an-
tibodies investigated label the M-band (Figs. 6 and 7, Table
I). The epitope of 
 
 
 
-Ob19–20 remains undetectable until af-
ter birth, suggesting that these domains may not be expressed
in the early embryonic isoforms. These data demonstrate that
obscurin is a sarcomeric protein, which is transiently detected
at the Z-disk and whose GDP/GTP exchange factor domain
is localized at the M-band of mature myofibrils.
 
Discussion
 
We describe here the identification of a new giant muscle pro-
tein, obscurin, which is part of the sarcomeric cytoskeleton.
Obscurin is a new member of the intracellular Ig superfamily,
and shows similarity to both titin and unc-89 in its modular
architecture. Yet it is different from both proteins and con-
tains additional domains previously unknown in vertebrate gi-
ant muscle proteins. It is therefore likely to perform a biologi-
cal role distinct from the known giant muscle proteins.
 
The obscurin gene
 
Obscurin is encoded by an 
 
 
 
150-kb gene, OBSCN, on
chromosome 1q42 with a structure reminiscent in part to
that of the titin gene in that individual Ig and Fn3 domains
are encoded by separate exons. The additional exons identi-
fied in the partial genomic sequence encode at least 10 addi-
tional Ig domains not present in the two cardiac isoforms
described here (Fig. 1 C). This suggests that even further
splice variants are likely to be expressed from this gene.
Three of the gaps in the partial gene sequence are localized
within the highly homologous tandem Ig domains, high-
lighting the value of our cDNA approach to complete the
genomic sequence based on the draft human genome. A de-
tailed analysis of the promoter and splice sites will be pre-
sented elsewhere.
 
The Ig domains: homology to titin and implications 
for sarcomeric function
 
Most of the obscurin primary structure is constructed from
intracellular Ig domains. The Ig domains are for the most
part joined without any linker sequences or insertions. This
arrangement of domains is most homologous to the tandem
Ig domains in the I-band region of titin. This suggests that
the titin and obscurin tandem Ig domains might fulfil analo-
gous functions in the sarcomere. The titin tandem Ig do-
mains have been shown to be an extensible chain that is
stretched at low forces and resists stretch at high forces
(Gautel and Goulding, 1996; Gautel et al., 1996b; Linke et
al., 1996). The isoforms obscurin and obscurin-a1 we de-
scribe here contain 52–57 Ig domains, each with a predicted
dimension of 
 
 
 
4 nm. Obscurin is therefore expected to
have a length of at least 208 nm. This is too short to span
whole sarcomeres or even A-bands but the protein could
link the M-band peripheries to other cytoskeletal structures,
which would also explain its low abundance. Whether ob-
scurin participates in cross-linking thick filaments in the
M-band or anchors M-band peripheries to other cytoskeletal
structures remains to be elucidated.
It is therefore plausible that obscurin acts as a flexible
linker between titin and other cellular structures at its ends.
The NH
 
2
 
- and COOH-terminal domains show less conser-
vation between them, arguing for functional diversity but
also for a rapid expansion of the central tandem Ig-region by
evolutionary recent duplication events. This expansion of
tandem Ig copies may be facilitated by the arrangement of
the Ig domains on individual exons (Fig. 1 C). Interestingly,
the arrangement of tandem Ig domains shows no discernible
super-repeat patterns similar to the I-band region of titin
(Gautel, 1996).
Figure 5. The obscurin IQ domain interacts with calmodulin in a 
Ca
  -independent manner. The expressed and purified obscurin 
fragment Ob51–52, which contains the IQ motif, is shown in lane
1. The binding of this fragment to either calmodulin-coupled 
Sepharose beads (lanes 2, 4, and 6), or to control beads coupled 
with an unrelated protein (lanes 3, 5, and 7), was analyzed in a pull-
down assay. The assay was carried out in the presence of 1 mM 
CaCl2 (lanes 2–5) or 1 mM EDTA (lanes 6 and 7). Bound protein was 
eluted from the beads with either 5 mM EDTA (lanes 2 and 3) or 6 M 
urea (lanes 4 to 7) and analyzed by SDS-PAGE and Coomassie blue 
staining. The obscurin fragment binds specifically to calmodulin 
both in the presence and absence of Ca
   and can be eluted under 
denaturing conditions (6 M urea), but not by chelating agents 
(EDTA). Elution by EDTA or urea is indicated by E or U, respectively.
 
Table I.
 
Developmental distribution of obscurin epitopes 
in developing hearts
Epitope
c8
somite
c9
somite
c10
somites
c11
somites rE14.5 NRC
 
 
 
-ob19–20 – – – – ND M
 
 -ob48–49 Z, diffuse Z ND Z, M M M
 -ob51–52 – diffuse M, diffuse ND M M
 -ob–DH – diffuse diffuse ND M M
Developmental distribution of obscurin epitopes in developing chicken and
mammalian hearts. Z, Z-disk; M, M-band; –, not detectable; c8-c11,
chicken somite stages; rE14.5, rat gestation day 14.5; NRC, neonatal rat
cardiomyocytes.130 The Journal of Cell Biology | Volume 154, 2001
In titin, the second function of the Ig domains is the in-
teraction with other sarcomeric proteins. Several of these
interactions are mediated via a pair of adjacent titin Ig do-
mains, including the interactions with the Z-disk protein
telethonin (Mues et al., 1998), the A-band protein myosin-
binding protein-C (Freiburg and Gautel, 1996) and the
M-band protein myomesin (Obermann et al., 1997). Ob-
scurin binds to two titin Ig domains, Z9 and Z10, both of
which are necessary for this interaction. Similarly, both ob-
scurin Ig domains Ob48 and Ob49 are required for this
homotypic interaction. The Ig domains at the NH2 and
COOH termini differ in sequence consensus, and it is
therefore likely that they will also be involved in ligand in-
teractions rather than in strictly mechanical functions.
However, transfections with several other obscurin frag-
ments did not identify further specific sarcomeric localiza-
tion signals. Similarly, extensive two-hybrid screening cov-
ering the NH2  and COOH termini failed to identify
further ligands. The understanding of the functions of ob-
scurin will therefore require the identification of further
protein interactions by other means. The two Fn3 domains
show homology to similar domains in titin and other sar-
comeric proteins. It is interesting to note that all sarco-
meric proteins containing Fn3 domains known to date are
associated with myosin (titin, twitchin, myomesin and
M-protein); in titin, Fn3 domains are found exclusively in
the thick filament region (Bennett and Gautel, 1996). Ob-
scurin, as a transiently Z-disk associated protein, may be
the first exception to this pattern; however, the function of
the two single Fn3 domains might be important for the as-
sociation with mature M-bands and remains to be further
elucidated.
Figure 6. Localization of endogenous 
obscurin. Localization of endogenous ob-
scurin (green with all antibodies) in neo-
natal rat cardiomyocytes demonstrates all 
four obscurin epitopes in association with 
the sarcomeric M-band (arrowheads). 
Obscurin visualized with  -Ob48–49 
colocalizes with myomesin (red in A–C) 
at the M-band (A) similar to the staining 
observed with  -Ob51–52 (B) and
 –Ob-DH (C). The epitope of  -Ob19–
20 is first detected after birth and is ini-
tially only weakly expressed (D), coun-
terstain with the titin Z-disk antibody 
T12 in red). Bar, 5  m.Obscurin, a giant sarcomeric Rho-GEF protein | Young et al. 131
The GEF domain
DH domains (also called Rho-GEF domains) catalyze the
exchange of GDP for GTP in small G-proteins of the Rho-
family (Hart et al., 1991), thereby activating G-protein–reg-
ulated signaling cascades (Cerione and Zheng, 1996). These
can lead to a multitude of cellular responses, ranging from
cytoskeletal reorganization with remodelling of the actin cy-
toskeleton to transcriptional regulation and cell cycle control
(Ridley, 1999; Bishop and Hall, 2000). DH domains are
invariably linked to a COOH-terminal PH domain. PH do-
mains are found also as independent domains in membrane-
associated proteins where they interact with phosphatidyl-
inositol-phosphates (PiP) (Musacchio et al., 1993). The DH
linked PH domains form a separate group, not all of which
are predicted to bind PIPs. Structural analysis of the unc-89
PH domain suggest it to be of a “nonliganding” type based
on its negative electrostatic potential (Blomberg et al., 1999).
Therefore, it is possible that the PH domains in the giant
muscle proteins unc-89 and obscurin do not play a role in
phospholipid signaling. This is supported by the sarcomeric,
rather than membrane localizations, of these PH domains in
muscle. However it is not possible to rule out PiP binding
for the obscurin PH domain based solely on its limited ho-
mology to UNC-89, especially since their isoelectric points
are very different (6.53 for unc-89 and 10.33 for obscurin).
The invariant presence of a PH domain adjacent to DH
domains suggests that they play a vital role in DH domain
function. This is probably best characterized for the Rho,
Cdc-42, and Rac1 GEF-protein Vav. In Vav, the GEF activ-
ity of the DH domain is dually autoinhibited by an NH2-
terminal helix blocking Rho-access to the DH domain by an
inhibitory tyrosine, and by the PH domain protecting this
closed conformation. Upon phosphorylation of PH-bound
PiP2 by PI3-kinase, the autoinhibitory tyrosine becomes ac-
cessible for phosphorylation by Src-like kinases and autoin-
hibition is fully relieved (Aghazadeh et al., 2000). The se-
quence of obscurin suggests that the same mechanism is
unlikely to regulate its GEF activity. Indeed, the recent crys-
tal structures of the Sos DHPH domain and of Rac1 in
complex with the DHPH domain of Tiam suggest that the
structural arrangement and regulatory mechanism of each
DHPH domain may be different (Worthylake et al., 2000).
Figure 7. Localization of endogenous 
obscurin in developing hearts demon-
strates a relocalization of epitopes dur-
ing development. Hearts of embryonic 
chicken (A–D) or mouse (E) are stained 
with antibodies raised against various 
obscurin epitopes (green). The titin
Z-disk epitope T-12 is stained in red and 
the actin cytoskeleton in blue. The re-
sulting color of titin and obscurin colo-
calization is yellow to bluish white here 
and in Fig. 8, depending on the back-
ground of blue actin staining. (A) Chick, 
8-somite stage: the  -Ob48–49 epitope 
colocalizes with titin T12 in dots or 
cross-striated patterns on actin-filaments 
at the cell periphery (arrows). (B) Chick, 
10-somite stage:  -Ob48–49 is predomi-
nantly colocalized with titin T12 at the 
Z-disk (arrows). (C) and (D) Chick, 10-
somite stage: the  -Ob51–52 and  –Ob-
DH epitopes, respectively, are diffusely 
localized or partly detected at the
M-band (arrowheads in D). M-band lo-
calization is observed in myofibrils with 
parallel arrangements but unaligned
myofibrils show diffuse localization (ar-
rows in D). (E) Mouse (E9.5) relocaliza-
tion of the  -Ob48–49 epitope is observed 
which shows prominent M-band and 
weaker Z-disk staining with  -Ob48–49. 
Note that the myofibrils in these hearts 
begin to align in parallel compared with 
the criss-cross patterns observed in early 
chicken hearts. Bar, 4  m.132 The Journal of Cell Biology | Volume 154, 2001
Interestingly, the obscurin DH domain contains a specific
polyproline stretch that might serve as an intramolecular
ligand for the SH3 domain, which may therefore also play a
regulatory role. However, efforts to elucidate the activation
mechanism of the obscurin DH domain have been frus-
trated by its lack of apparent activity upon transfection in
cultured cells and its insoluble expression in any systems
tried to date. Clearly, understanding the cellular functions of
obscurin’s GEF domain will require the future combination
of a wide range of methods, including genetic approaches.
The IQ motif
IQ motifs are Ca
2 -dependent as well as Ca
2 -independent
calmodulin binding motifs (Rhoads and Friedberg, 1997) in
proteins as diverse as Ca-insensitive protein kinase A, utro-
phin, dynein, and several G-protein regulating proteins like
Ras-GRF. In Ras-GRF, Ca
2 -mediated binding of calmodu-
lin was shown to activate the nucleotide exchange activity of
the Cdc25 Ras-GRF domain (Farnsworth et al., 1995). Our
genetic and in vitro binding assays with the obscurin frag-
ment Ob51–52 demonstrate that the obscurin IQ motif is a
functional motif that interacts in a Ca
2 -independent man-
ner with calmodulin. Though calmodulin binding is Ca
2 -
independent it is plausible that the bound calmodulin may
act as a Ca
2  sensor which could confer Ca
2  sensitivity to
some aspect of obscurin function. In Ras-GRF, the IQ motif
is found in the immediate vicinity of the catalytic Cdc25 do-
main. In obscurin, the IQ motif is separated from the
DH domain by a further four Ig domains, suggesting that
CaM binding to obscurin modulates activities other than
guanine nucleotide exchange. In neuromodulin and neuro-
granin, CaM binding is abrogated by PKC phosphorylation
(Chakravarthy et al., 1999); the phosphorylation site SFR in
these proteins is changed to AFK in obscurin, making a sim-
ilar mechanism unlikely.
Obscurin expression and sarcomeric integration
Our analysis of the incorporation of obscurin into the sarco-
mere, using four independent antibodies, reveals a complex
picture. By its secondary structure of tandem Ig domains, a
localization in the I-band like titin would have been most
plausible. Ob48–49 interacts with titin Z9-Z10 in transfec-
tions and binding assays. In agreement with this, the epitope
 -Ob48–49 is localized to the Z-disk in chicken embryos up
to about the 10 somite stage. However, at later stages in ma-
ture myofibrils, both in vivo (embryonic heart whole
mounts) as well as in cultured cells,  -Ob48–49 colocalizes
in the M-band with the other obscurin epitopes which were
initially diffuse or absent. This suggests that the obscurin–
titin interaction may be transient and developmentally regu-
lated. Failure to detect some obscurin epitopes, like ObDH
or Ob19–20 at early stages or their change in localization at
later stages could also be due to epitope masking, although
we feel this possibility is less likely as all antibodies show
similar behavior. Alternatively, it is possible that the regions
of obscurin which are responsible for targeting it to the M-
band are either spliced out, leading to the sequential appear-
ance of different obscurin isoforms, or they are switched off,
e.g., by phosphorylation at early developmental stages. Iden-
tification of such targeting signals will be a key to under-
standing this putative Z-disk to M-band translocation. A se-
quential appearance, and integration, of different epitopes
is also observed for titin. In titin, the M-band region be-
comes organized after the incorporation of the Z-disk an-
choring NH2-terminal region, and transiently colocalizes
with the NH2-terminal region (Fürst et al., 1988; Van der
Loop et al., 1996; Ehler et al., 1999; Van der Ven et al.,
1999). Some titin M-band epitopes are apparently masked
at this stage (Van der Ven et al., 1997). The LIM protein
DRAL is found both in the M-band and the Z-disk in heart
muscle, suggesting that certain signaling molecules can com-
municate with both compartments (Scholl et al., 2000). Re-
cently, a putative titin kinase regulator was also found at the
Z-disk despite its interaction with M-band titin (Centner et
al., 2001), and a substrate for titin kinase, telethonin, is also
found at the Z-disk (Mayans et al., 1998). Similarly, it
seems that obscurin isoforms can occupy different sarco-
meric binding sites in a developmentally regulated way, and
that therefore the signaling functions of obscurin during
early stages of muscle development may be different from
mature muscle. The possible obscurin analogue unc-89 is
also found at the M-band, but its developmental integration
is unknown (Benian et al., 1996).
Analysis of the distribution of obscurin in early embryonic
hearts compared with later stages demonstrates that Z-disk
association of the protein is mainly observed in cells where
the actin cytoskeleton is not yet regularly aligned in parallel
myofibrils, but rather along the cell membranes and in an ir-
regular, criss-cross pattern (Fig. 7, A–D). M-band localiza-
tion is observed in cells where myofibrils begin to be ar-
ranged in parallel bundles in the cell centre (Fig. 7 E). In
mature cardiomyocytes, myofibrils are arranged in parallel
and obscurin is found at the M-band (Figs. 6 and 8). This
coincidence of the redistribution of obscurin epitopes with
remodelling of the actin cytoskeleton suggests that obscurin
may be involved in this structural transition.
The mechanisms that control the rearrangement of the ac-
tin cytoskeleton during myofibrillogenesis are to date un-
known. It is interesting to note that DH domains in other
cytoskeletal proteins, like trio, (Debant et al., 1996) activate
GTPases of the Rho family, which are involved in actin cy-
toskeletal reorganization, like the formation of stress fibres
by Rho and membrane ruffling induced by Rac. It is com-
pelling to speculate that the SH3-DH-PH triad in obscurin
could be involved in signaling by Rho-like GTPases neces-
sary for the cytoskeletal rearrangement during myofibrillo-
genesis. However, transfection assays with the obscurin
SH3-DH-PH motif into neonatal rat cardiomyocytes, or
into C2C12 myoblasts, did not lead to apparent changes in
the actin cytoskeleton or in perturbations of sarcomere as-
sembly (not shown). This suggests that the obscurin GEF
domain is tightly regulated and that full activity may require
specific activation steps within the correct cellular context.
Recent evidence suggests that Rho-like GTPases also play
crucial roles in the control of muscle gene transcription dur-
ing development and hypertrophy (Finkel, 1999; Chien,
2000; Clerk and Sugden, 2000). Unlike nonmuscle cells,
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nantly on the regulation of gene expression rather than of
actin morphology (Thorburn et al., 1997). The GEF pro-
teins responsible for this muscle-specific signaling pathway
are unknown. Our identification of a Rho-GEF in the verte-
brate sarcomere is the first evidence that direct communica-
tion between the sarcomere and the G-protein pathways
leading to new sarcomere formation may be possible.
Materials and methods
Cloning of cDNA Constructs
The cDNA constructs for yeast two-hybrid analysis, transfection, and pro-
tein expression were amplified by PCR. For titin total human cardiac cDNA
(CLONTECH Laboratories, Inc.) was used as the template and primer design
was based on the human cardiac titin sequence (EMBL/GenBank/DDBJ ac-
cession no. X90568). Domain nomenclature for titin is as described in La-
beit and Kolmerer, (1995b). All cloning procedures followed standard pro-
tocols (Ausubel et al., 1995). The identity of the derived constructs was
verified by restriction digest and in some cases by DNA sequencing.
The constructs used (with the amino acid residues in brackets) were
as follows: titin, Z7–Z10 (1,406–1,885), Z7–Z8 (1,406–1,604), and Z9–
Z10 (1,657–1,885); obscurin, Ob19–Ob20 (1,711–1,897), Ob48–Ob49
(4,334–4,521), Ob48–Ob51 (4,334–4,714), Ob51–Ob52 (4,619–4,991),
and ObDH (5,678–5,886).
Yeast two-hybrid screening and analysis
Titin Z7-Z10 or obscurin Ob51-Ob52 constructs were cloned into a modi-
fied pLexA vector for screening. Two-hybrid screening and analysis were
performed as described previously (Young et al., 1998).
 -phage library screening and sequencing
A human cardiac muscle  -Zap II cDNA (936208; Stratagene) was
screened with obscurin cDNA probes and cDNA clones were isolated us-
ing standard protocols (Ausubel et al., 1995). Inserts were sequenced from
in vivo excised pBluescript SK plasmids manually and in some cases by
SeqLab laboratories. In some cases, nested deletions were generated using
Exonuclease III/Mung bean nuclease (Stratagene). Sequence data were
compiled and analyzed using the Wisconsin Genetics Computer Group
(GCG) package (Devereux et al., 1984). Database searches were
performed at the National Centre for Biotechnology Information (www.
ncbi.nlm.nih.gov) using the BLAST search service (Altschul et al., 1997).
Multiple sequence alignments were prepared using Pileup (GCG package)
and ClustalW (Higgins et al., 1996). The complete obscurin cDNA se-
quence has been deposited in EMBL/GenBank/DDBJ under accession no.
AJ002535.
Genomic sequence analysis
A search of the obscurin cDNA sequence against the draft human genome
sequence was carried out using the ENSEMBL server (www.ensembl.org).
Three clones were found to contain parts of the obscurin gene (EMBL/Gen-
Bank/DDBJ accession nos. AL359510, AL353593, and AC026657). Con-
tigs from these clones were correctly ordered and oriented according to
the cDNA sequence. Combining information from these clones allowed
some gaps to be filled and gave an overall gene structure consisting of 10
contigs and 9 gaps. Sequence analysis was done using the GCG package
of sequence analysis programs (Devereux et al., 1984). Annotation of the
genomic sequence was done using the Artemis software (The Sanger Cen-
tre). The sequences have been deposited in EMBL/GenBank/DDBJ under
accession nos. AJ314896, AJ314898, AJ314900, AJ341901, AJ314903,
AJ314904, AJ314905, AJ314906, AJ314907, and AJ314908.
Protein expression and purification
Titin Z9-Z10 and obscurin Ob19-Ob20, Ob48-Ob49, Ob51-Ob52, and
ObDH fragments were expressed with an NH2-terminal 6-histidine tag and
a tobacco etch virus protease cleavage site in the Escherichia coli strain
BL21[DE3] (Young et al., 1998). Phasing of the domains was done in anal-
ogy to titin Ig domains (Politou et al., 1994). Initial purification was carried
out on Ni-NTA agarose columns (QIAGEN). Further purification was car-
ried out by ion exchange chromatography on a MonoQ or S-Sepharose
column (Amersham Pharmacia Biotech). The ObDH construct was
expressed insolubly and solubilized and purified on Ni-NTA agarose in
presence of 6 M urea. The purified protein was then dialyzed in 20 mM
Tris-HCl, pH 8, 1 mM DTT, 1 mM EDTA. For immunization and binding ex-
periments, histidine tags were cleaved off by a tobacco etch virus protease.
Ni column binding assay
50  g of each of the protein fragments titin Z9-Z10 and obscurin Ob48-
Ob49 were mixed in a total volume of 400  l binding buffer (20 mM
K2HPO4/KH2PO4, pH 8, 50 mM NaCl, 5 mM imidazole, 0.02% Triton
X-100, 20 mM  -mercaptoethanol), and loaded on a minicolumn packed
with 50  l Ni-NTA agarose (QIAGEN). After washing with 2   100  l
binding buffer, bound proteins were eluted in 100  l of elution buffer (200
mM imidazole, 20 mM  -mercaptoethanol). The flow through, wash, and
eluate fractions were collected and analyzed on 15% SDS-PAGE gels
(Laemmli, 1970). As a control, the same procedure was followed for the
obscurin fragment Ob48-Ob49 alone.
Figure 8. Localization of endogenous 
obscurin (green for all antibodies) in 
E14.5 rat hearts. At this developmental 
stage, myofibrils are arranged in mature, 
parallel bundles and all obscurin 
epitopes detectable at this stage are 
found at the M-bands, as shown by
the alternating staining pattern with
Z-disk titin (T12, red; F-actin, blue). (A) 
 -Ob48–49; (B)  -Ob51–52; (C)  –Ob-
DH. Bar, 10  m.134 The Journal of Cell Biology | Volume 154, 2001
Calmodulin binding assay
The obscurin fragment Ob51–52 was incubated with 50  l of either cal-
modulin-coupled Sepharose beads (Amersham Pharmacia Biotech) or with
beads coupled to an unrelated protein. After 30 min incubation beads
were washed with 3   100  l assay buffer (20 mM HEPES, pH 7, 50 mM
NaCl, 1 mM DTT with either 1 mM CaCl2 or 1 mM EDTA). Bound protein
was eluted from the beads with either 5 mM EDTA or 6 M urea and ana-
lyzed by SDS-PAGE.
Antibodies
Polyclonal rabbit sera against recombinant proteins were raised using a
standard immunization protocol. The obscurin fragments used as antigens
were Ob19–20, Ob48–49, Ob51–52, and ObDH. The antisera were affin-
ity-purified essentially as described (Harlow and Lane, 1988). For Western
blotting, the antibodies NSH3 (raised against the SH3 domain of nebulin,
EMBL/GenBank/DDBJ accession no. X83957; residues 6,604–6,669) and
S53-4 (which specifically binds to an epitope of I-band titin in the skeletal
N2-A isoform; Gautel et al., 1996b) were used. For immunofluorescence,
the T12 monoclonal antibody, which recognizes a Z-disk epitope of titin
(Fürst et al., 1988), or the antibody B4 against myomesin (Grove et al.,
1984) were used.
Western blotting
Human Vastus lateralis muscle was a gift from Professor Allenberg (Heidel-
berg University, Heidelberg, Germany). Protein samples were prepared by
homogenizing the tissue under liquid nitrogen and then solubilizing in
Laemmli sample buffer at 90 C by vortexing. Agarose reinforced 3 or 4%
polyacrylamide SDS gels were prepared according to Tatsumi and Hattori
(1995) and electrophoresis of protein samples carried out according to
(Laemmli, 1970). Proteins were blotted onto nitrocellulose membranes for
2–3 h at 0.8 mA/cm
2 in a SemiPhor blotting apparatus (Hoefer Scientific
Instruments) and major bands on the blots detected by Ponceau S staining.
One lane was cut from each gel before blotting and analyzed by Coo-
massie staining. Probing of blots with various antibodies followed standard
procedures (Harlow and Lane, 1988) using ECL (Amersham Pharmacia
Biotech). Stripping of blots for subsequent reprobing was achieved by
washing for 30 min in SDS-PAGE running buffer at 95 C. Quantitation of
band density from double-labeled blots was carried out using the NIH Im-
age software.
Immunofluorescence
Whole mount preparations. Hearts were dissected from 2-d-old chicken
embryos (staged by counting the somites) or from embryo day (E)9.5 mouse
and E14.5 rat embryos, and fixed for 1–1.5 h in 4% PFA/PBS. After brief
washing in PBS, the hearts were treated with 1 mg/ml hyaluronidase
(Sigma-Aldrich) for 30 min (45 min for the rat). After washing with PBS, the
hearts were permeabilized with 0.2% Triton X-100 in PBS for 30 min (45
min for the rat). Unspecific binding sites were blocked by incubation with
5% normal (preimmune) goat serum in 1% BSA/TBS for at least 30 min (45
min for the rat). Incubations with primary and secondary antibodies at their
appropriate dilutions were performed at 4 C on a rocking table over night.
After the antibody incubations, the specimen were washed in an excess of
PBT (0.002% Triton X-100 in PBS) for at least 6 h with buffer changes every
30 min. After the immunostaining, the specimens were mounted on slides
in mounting medium (0.1 M Tris-HCl, pH 9.5, glycerol, 3:7) containing 50
mg/ml n-propyl gallate as an antifading reagent (Ehler et al., 1999).
Confocal microscopy. An inverted microscope (DM IRB/E; Leica)
equipped with a true confocal scanner (TCS NT; Leica), a 63 /1.4 oil im-
mersion objective (PL APO; Leica), and an argon/krypton mixed gas laser
was used for the recording of confocal data sets. Image processing was
performed on a Silicon Graphics workstation using “Imaris” (Bitplane AG),
a three-dimensional multichannel image processing software specialized
for confocal microscopy images.
Cell culture and transfection. Neonatal rat cardiomyocytes were isolated
from day three Wistar rats as described previously (Sen et al., 1988; Ko-
miyama et al., 1996). The cells were plated on collagen-coated 35-mm
dishes and grown in M199 medium, 5% fetal bovine serum, 5% horse se-
rum, 10  M cytosine-arabinoside, and 10  M phenylephrine for 3 d days
at 37 C. Cells were fixed in 2% paraformaldehyde and processed for im-
munofluorescence microscopy following standard methods. For transfec-
tions, obscurin fragments were cloned into a modified pCMV-5 vector
(Andersson et al., 1989) with an NH2-terminal T7-tag
® sequence (MTG-
GQQMGR). Plasmid DNA was transfected using a modified CaPO4 proto-
col (Komiyama et al., 1996). After transfection, cells were cultured for an-
other 48 h before fixing and staining. The transfected obscurin fragments
were detected with the mouse monoclonal anti-T7 tag antibody (Novabio-
gen). Counterstaining was carried out using titin T12 or myomesin B4
monoclonal antibodies, or rhodamine-phalloidin for F-actin.
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